Fisher-Wallace Laboratories is the culmination of events set in motion when entrepreneur Chip Fisher and Dr. Martin Wallace, PhD, CCN, CAd, found an FDA sanctioned product that truly meets a vastly important need: the non-drug treatment of depression, anxiety, stress and insomnia.

Wallace learned of what was then called the LISS Cranial Stimulator in late 2001, when a friend introduced him to Dr. Saul Liss. At that juncture, Wallace—despite his PhD in biology and his credentials in treating addictions and other compulsive behaviors—had been unable to find any means of coping with the deep incapacitating depression that brought him to a standstill in the aftermath of 9/11 and the eight hours he spent trapped in a building at Ground Zero. Dr. Liss offered Wallace the use of a Cranial Stimulator, which successfully treated his depression.

Wallace eventually began working with Saul Liss, helping him to improve the machine’s design and gaining useful feedback from physicians who purchased the device for their patients.

Fisher, an entrepreneur who combines practicality with vision, was introduced to the Cranial Stimulator when he met Wallace at a business conference. Fisher was particularly impressed by the Cranial Stimulator’s lack of side effects, and ability to stimulate the brain’s production of neurochemicals.

The FDA allows Fisher Wallace Laboratories to market the Cranial Stimulator for the treatment of depression, anxiety and insomnia. In 2006, Fisher-Wallace Laboratories purchased the patents for each of the micro-current frequencies which—when combined for transcranial stimulation—have been shown to cause the brain to produce serotonin, dopamine and other neurotransmitters associated with normalizing moods, sleep, as well as lower the multiply-harmful cortisol levels that result during long-term stress.

Saul Liss passed away in June, 2006 at the age of 84. Fisher-Wallace Laboratories continues his unique work. The company manufactures and markets the Fisher Wallace Cranial Stimulator (FW-100), ensuring its availability for those who prefer to be treated for insomnia, depression, anxiety without drugs.

The company has an impressive list of ground-breaking research projects ongoing in the field of electrocranial stimulation. Renowned institutions such as Harvard Medical School, Columbia Medical School, Massachusetts General Hospital and the University of Medicine and Dentistry of New Jersey.

Chip Fisher, President of Fisher Wallace Laboratories

The son of stereo pioneer Avery Fisher, Chip Fisher earned his BA from Harvard University in 1978. After graduation, he worked for IBM in the Data Processing Division.  He later founded and sold several companies before founding Fisher Wallace Labs in 2006 with the late Martin Wallace, PhD.  Chip serves on the boards of the Avery Fisher Artists Program and the Virtual Music Academy.  He resides in New York City.